News / Business
(IMMU, CCI, BPAX) are Today’s Most Active Stocks - Stock News
Active Stocks
Immunomedics, Inc. (NASDAQ:IMMU) jumped 7.04% to $4.87 with a massive volume of 1.22 million shares. The stock has a 52-week range of $0.84-$7.16. Today the company announced further topline results for UCB's new SLE drug candidate epratuzumab. UCB's Phase IIb dose and regimen-ranging 12-week study compared epratuzumab to placebo in patients with SLE (also commonly known as lupus). In this study all epratuzumab doses, which ranged from 200 mg to 3600 mg cumulative dose administered during one 12-week treatment cycle, had numerically superior response rates compared to placebo at week 12. The primary objective was to assess the dose response and the dose frequency for epratuzumab. Immunomedics, Inc. (Immunomedics) is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) augmented 9.34% to $1.99 on an unusual volume of 610k shares. BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc. announced the completion of their previously announced merger of Cell Genesys, Inc. with and into BioSante Pharmaceuticals, Inc., with BioSante Pharmaceuticals, Inc. as the surviving company, under which BioSante Pharmaceuticals, Inc. now has acquired all of the outstanding shares of Cell Genesys, Inc. common stock. The combined company`s ownership composition consists of approximately 62% from BioSante Pharmaceuticals, Inc. stockholders and 38% from the former Cell Genesys, Inc. stockholders. The stock has a 52-week range of $0.81-$3.89. Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism.
Crown Castle International Corp. (NYSE:CCI) added $1.50 or 4.62% over its previous day’s price and now trades at $34.00 on massive volume of 1.92 million shares on no news. The stock has a 52-week range of $8.75-$34.36. Today the stock has also created a new 52-week high of $34.36. Crown Castle International Corp. (CCIC) owns, operates and leases towers and other communication structures, including certain rooftop installations (collectively, towers), for wireless communications. Its core business is renting space on its towers via long-term contracts in various forms, including license and lease agreements.
ABOUT PennyStockPickReport.com
Penny Stock Pick Report is one of the leading stock web site that provides free stock alerts and tracks small cap penny stocks that could be on the brink of a massive breakout. If you wish to get your company featured on our website then please contact us at info[at]PennyStockPickReport
